| 2024-06-30 |
Increased blood CSF3R+myeloid-derived suppressor cell is a predictor for breast cancer recurrence |
American Journal of Cancer Research. 2024 Jun 30;14(6):3171-3185. |
 |
| 2024-03 |
RNF43 inactivation enhances the B-RAF/MEK signaling and greates a combinatory therapeutic target in cancer cells |
Advanced Science. 2024 Mar;11(12):Article number e2304820. |
|
| 2024-02-15 |
Neuron-derived neurotensin promotes pancreatic cancer invasiveness and gemcitabine resistance via the NTSR1/Akt pathway |
American Journal of Cancer Research. 2024 Feb 15;14(2):448-466. |
|
| 2023-09-05 |
単離抗体,医薬組成物,単離抗体結合体,ダイマー化阻害方法,シグナル伝達阻害方法,管新生阻害方法,治療方法,および断片検出方法 |
JP7339325/2023-09-05 |
|
| 2023-09-01 |
可標靶ＶＥＧＦＲ２與ＶＥＧＦＲ３的雙功能抗體 |
TWI813649/2023-09-01 |
|
| 2023-08-15 |
Pancreatic cancer cell-derived semaphorin 3A promotes neuron recruitment to accelerate tumor growth and dissemination |
American Journal of Cancer Research. 2023 Aug 15;13(8):3417-3432. |
|
| 2023-04-11 |
Dual-function antibodies targeting VEGFR2 and VEGFR3 |
US11623960/2023-04-11 |
|
| 2023-03-30 |
Dual-function antibodies targeting VEGFR2 and VEGFR3 |
AU2019239984/2023-03-30 |
|
| 2023-02-01 |
Protein arginine methyltransferase 3: A crucial regulator in metabolic reprogramming and gene expression in cancers |
Cancer Letters. 2023 Feb 1;554:Article number 216008. |
|
| 2023-01-20 |
ARID1A loss in pancreas leads to islet developmental defect and metabolic disturbance |
iScience. 2023 Jan 20;26(1):Article number 105881. |
|
| 2023-01 |
Mitochondrial phosphoenolpyruvate carboxykinase promotes tumor growth in estrogen receptor-positive breast cancer via regulation of the mTOR pathway |
Cancer Medicine. 2023 Jan;12(2):1588-1601. |
|
| 2022-12-15 |
Skp2-mediated Zeb1 expression facilitates cancer migration by a ubiquitination-independent pathway |
Life Sciences. 2022 Dec 15;311(Part A):Article number 121135. |
|
| 2022-11-06 |
PTEN regulates invasiveness in pancreatic neuroendocrine tumors through DUSP19-mediated VEGFR3 dephosphorylation |
Journal of Biomedical Science. 2022 Nov 06;29:Article number 92. |
|
| 2022-10-20 |
Reprogramming of sentinel lymph node microenvironment during tumor metastasis |
Journal of Biomedical Science. 2022 Oct 20;29:Article number 84. |
|
| 2022-04-18 |
The trinity: Interplay among cancer cells, fibroblasts, and immune cells in pancreatic cancer and implication of CD8(+) T cell-orientated therapy |
Biomedicines. 2022 Apr 18;10(4):Article number 926. |
|
| 2022-02-24 |
Semaphorin 6C suppresses proliferation of pancreatic cancer cells via inhibition of the AKT/GSK3/beta-catenin/cyclin D1 pathway |
International Journal of Molecular Sciences. 2022 Feb 24;23(5):Article number 2608. |
|
| 2022-02-15 |
Semaphorin 4C promotes motility and immunosuppressive activity of cancer cells via CRMP3 and PD-L1 |
American Journal of Cancer Research. 2022 Feb 15;12(2):713-728. |
|
| 2021-01 |
Lysine demethylase 2A expression in cancer-associated fibroblasts promotes breast tumour growth |
British Journal of Cancer. 2021 Jan;124(2):484-493. |
|
| 2021-01 |
c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation |
Cancer Science. 2021 Jan;112(1):243-253. |
|
| 2020-11-28 |
Comprehensive transcriptomic analysis identifies ST8SIA1 as a survival-related sialyltransferase hene in breast cancer |
Genes. 2020 Nov 28;11(12):Article number 1436. |
|
| 2020-10-19 |
Single-cell analysis reveals immune modulation and metabolic switch in tumor-draining lymph nodes |
OncoImmunology. 2020 Oct 19;9(1):Article number 1830513. |
|
| 2020-01 |
Prognostic role of RECK in pathological outcome-dependent buccal mucosa squamous cell carcinoma |
Oral Diseases. 2020 Jan;26(1):62-71. |
|
| 2019-08-06 |
Cancer-derived VEGF-C increases chemokine production in lymphatic endothelial cells to promote CXCR2-dependent cancer invasion and MDSC recruitment |
Cancers. 2019 Aug 6;11(8):Article number 1120. |
|
| 2019-07 |
Protein arginine methyltransferase 3-induced metabolic reprogramming is a vulnerable target of pancreatic cancer |
Journal of Hematology and Oncology. 2019 Jul;12:Article number 79. |
|
| 2019-06-24 |
Alteration of epigenetic modifiers in pancreatic cancer and its clinical implication |
Journal of Clinical Medicine. 2019 Jun 24;8(6):Article number 903. |
|
| 2019-05-27 |
Deciphering the potential role of hox genes in pancreatic cancer |
Cancers. 2019 May 27;11(5):Article number 734. |
|
| 2019-05-20 |
Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer |
Molecular Cancer. 2019 May 20;18:Article number 96. |
|
| 2019-03-21 |
Two birds, one sone: Double hits on tumor growth and lymphangiogenesis by targeting vascular endothelial growth factor receptor 3 |
Cells. 2019 Mar 21;8(3):Article number 270. |
|
| 2019-03 |
Mutant Kras-induced upregulation of CD24 enhances prostate cancer stemness and bone metastasis |
Oncogene. 2019 Mar;38(12):2005-2019. |
|
| 2019-01-02 |
FAK is required for tumor metastasis-related fluid microenvironment in triple-negative breast cancer |
Journal of Clinical Medicine. 2019 Jan 2;8(1):Article number 38. |
|
| 2019-01 |
Identification of the novel role of CD24 as an oncogenesis regulator and therapeutic target for triple negative breast cancer |
Molecular Cancer Therapeutics. 2019 Jan;18(1):147-161. |
|
| 2019-01 |
Beta-catenin-activated autocrine PDGF/Src signaling is a therapeutic target in pancreatic cancer |
Theranostics. 2019 Jan;9(2):324-336. |
|
| 2018-12-20 |
Protein arginine methyltransferase 3 enhances chemoresistance in pancreatic cancer by methylating hnRNPA1 to increase ABCG2 expression |
Cancers. 2018 Dec 20;11(1):Article number 8. |
|
| 2018-12 |
c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation |
Cancer Science. 2018 Dec;109(Suppl. 2):866. |
|
| 2018-11-13 |
From friend to enemy: Dissecting the functional alteration of immunoregulatory components during pancreatic tumorigenesis |
International Journal of Molecular Sciences. 2018 Nov 13;19(11):Article number 3584. |
|
| 2018-09-15 |
Preprogramming therapeutic response of PI3K/mTOR dual inhibitor via the regulation of EHMT2 and p27 in pancreatic cancer |
American Journal of Cancer Research. 2018 Sep 15;8(9):1812-1822. |
|
| 2018-09-06 |
Cell motility facilitated by mono(2-ethylhexyl) phthalate via activation of the AKT-beta-catenin-IL-8 axis in colorectal cancer |
Journal of Agricultural and Food Chemistry. 2018 Sep 6;66(37):9635-9644. |
|
| 2018-02-19 |
Pyruvate kinase M2 fuels multiple aspects of cancer cells: From cellular metabolism, transcriptional regulation to extracellular signaling |
Molecular Cancer. 2018 Feb 19;17:Article number 35. |
|
| 2018-01 |
Orchestration of H3K27 methylation: Mechanisms and therapeutic implication |
Cellular and Molecular Life Sciences. 2018 Jan;75(2):209-223. |
|
| 2018-01 |
The role of aberrant mitochondrial phosphoenolpyruvate carboxykinase expression in pancreatic neuroendocrine tumors |
Cancer Science. 2018 Jan;109(Suppl. 1):466. |
|
| 2017-10-09 |
Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) regulates the cell metabolism of pancreatic neuroendocrine tumors (pNET) and de-sensitizes pNET to mTOR inhibitors |
Oncotarget. 2017 Oct 09;8(61):103613-103625. |
|
| 2017-10 |
The NuRD complex-mediated p21 suppression facilitates chemoresistance in BRCA-proficient breast cancer |
Experimental Cell Research. 2017 Oct;359(2):458-465. |
|
| 2017-09-16 |
The regulatory role of aberrant Phosphatase and Tensin Homologue and Liver Kinase B1 on AKT/mTOR/c-Myc axis in pancreatic neuroendocrine tumors |
Oncotarget. 2017 Sep 16;8(58):98068-98083. |
|
| 2017-09 |
G9a governs colon cancer stem cell phenotype and chemoradioresistance through PP2A-RPA axis-mediated DNA damage response |
Radiotherapy and Oncology. 2017 Sep;124(3):395-402. |
|
| 2017-09 |
KLF10 loss in the pancreas provokes activation of SDF-1 and induces distant metastases of pancreatic ductal adenocarcinoma in the KrasG12D p53flox/flox model |
Oncogene. 2017 Sep;36(39):5532-5543. |
|
| 2017-09 |
A phase II study of Arginine Deiminase (ADI-PEG20) in relapsed/refractory or poor-risk acute myeloid leukemia patients |
Scientific Reports. 2017 Sep;7:Article number 11253. |
|
| 2017-08-07 |
Lysine demethylase KDM2A inhibits TET2 to promote DNA methylation and silencing of tumor suppressor genes in breast cancer |
Oncogenesis. 2017 Aug 7;6:Article number e369. |
|
| 2017-08 |
Fine needle aspiration combined with matrix-assisted laser desorption ionization time-of-flight/mass spectrometry to characterize lipid biomarkers for diagnosing accuracy of breast cancer |
Clinical Breast Cancer. 2017 Aug;17(5):373-381.e1. |
|
| 2016-11 |
Role of epigenetic regulator EHMT2 in the regulation of gemcitabine resistance in pancreatic cancer |
Journal of Gastroenterology and Hepatology. 2016 Nov;31(Suppl. 3):245. |
|
| 2016-09 |
The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer |
Oncotarget. 2016 Sep;7(38):61136-61151. |
|
